首页 > 最新文献

Laparoscopic surgery最新文献

英文 中文
Results after minimally invasive Toupet fundoplication technique: a narrative review 微创Toupet扩底术后的疗效回顾
Pub Date : 2021-01-25 DOI: 10.21037/LS-20-101
E. Ugliono, Elisabetta Seno, M. Allaix, F. Rebecchi, M. Morino
Posterior partial fundoplication (PPF) was developed as an alternative surgical strategy to Nissen fundoplication, in attempt to reduce the rate of side-effects, mainly dysphagia and gas bloat syndrome. Allowing patients to maintain belching ability, this operation could lead to minor gas-related symptoms than total fundoplication. The procedure was first described by Andrè Toupet in 1963 and consisted of a posterior 180° wrap of the gastric fundus through a midline incision. After the first report of anti-reflux surgery performed with the laparoscopic approach, several authors have translated PPF into a minimally invasive approach. A review of literature has been performed to evaluate the results of minimally invasive PPF, focusing on the rate of dysphagia and gastro-esophageal reflux disease (GERD) recurrence. The evidence suggests that laparoscopic PPF is a safe and feasible procedure, and provides similar reflux control compared to laparoscopic total fundoplication, with lower risk of postoperative dysphagia. However, the duration of laparoscopic PPF effect on reflux control over time is questioned, as data on long-term results after laparoscopic Toupet fundoplication are lacking. Further studies are needed to provide long-term functional and clinical results of laparoscopic PPF in order to draw definitive conclusions. Therefore, the controversy regarding the optimal surgical strategy for the management of gastroesophageal reflux continues.
后部分胃底折叠术(PPF)是Nissen胃底折叠的一种替代手术策略,旨在降低副作用的发生率,主要是吞咽困难和气胀综合征。与全胃底折叠术相比,这种手术可以使患者保持打嗝能力,从而导致轻微的气体相关症状。该手术由AndrèToupet于1963年首次描述,包括通过中线切口对胃底进行180°后包裹。在首次报道腹腔镜入路抗反流手术后,几位作者将PPF转化为微创入路。对文献进行了综述,以评估微创PPF的结果,重点是吞咽困难和胃食管反流病(GERD)复发率。有证据表明,腹腔镜PPF是一种安全可行的手术,与腹腔镜全胃底折叠术相比,它提供了类似的反流控制,术后吞咽困难的风险较低。然而,随着时间的推移,腹腔镜PPF对反流控制的作用持续时间受到质疑,因为缺乏腹腔镜Toupet胃底折叠术后长期结果的数据。需要进一步的研究来提供腹腔镜PPF的长期功能和临床结果,以便得出明确的结论。因此,关于胃食管反流最佳手术策略的争论仍在继续。
{"title":"Results after minimally invasive Toupet fundoplication technique: a narrative review","authors":"E. Ugliono, Elisabetta Seno, M. Allaix, F. Rebecchi, M. Morino","doi":"10.21037/LS-20-101","DOIUrl":"https://doi.org/10.21037/LS-20-101","url":null,"abstract":"Posterior partial fundoplication (PPF) was developed as an alternative surgical strategy to Nissen fundoplication, in attempt to reduce the rate of side-effects, mainly dysphagia and gas bloat syndrome. Allowing patients to maintain belching ability, this operation could lead to minor gas-related symptoms than total fundoplication. The procedure was first described by Andrè Toupet in 1963 and consisted of a posterior 180° wrap of the gastric fundus through a midline incision. After the first report of anti-reflux surgery performed with the laparoscopic approach, several authors have translated PPF into a minimally invasive approach. A review of literature has been performed to evaluate the results of minimally invasive PPF, focusing on the rate of dysphagia and gastro-esophageal reflux disease (GERD) recurrence. The evidence suggests that laparoscopic PPF is a safe and feasible procedure, and provides similar reflux control compared to laparoscopic total fundoplication, with lower risk of postoperative dysphagia. However, the duration of laparoscopic PPF effect on reflux control over time is questioned, as data on long-term results after laparoscopic Toupet fundoplication are lacking. Further studies are needed to provide long-term functional and clinical results of laparoscopic PPF in order to draw definitive conclusions. Therefore, the controversy regarding the optimal surgical strategy for the management of gastroesophageal reflux continues.","PeriodicalId":92818,"journal":{"name":"Laparoscopic surgery","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-01-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41428133","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Variables in the Danish Hernia Databases: inguinal and ventral 丹麦疝数据库中的变量:腹股沟和腹侧
Pub Date : 2021-01-18 DOI: 10.21037/LS-20-125
J. Rosenberg, H. Friis-Andersen, L. Jørgensen, K. Andresen
Department of Surgery, Herlev Hospital, Herlev, Denmark; University of Copenhagen, København, Denmark; Department of Surgery, Horsens Hospital, Horsens, Denmark; Department of Surgery, Bispebjerg Hospital, København, Denmark Contributions: (I) Conception and design: All authors; (II) Administrative support: None; (III) Provision of study materials or patients: None; (IV) Collection and assembly of data: All authors; (V) Data analysis and interpretation: All authors; (VI) Manuscript writing: All authors; (VII) Final approval of manuscript: All authors. Correspondence to: Jacob Rosenberg. Department of Surgery, Herlev Hospital, Herlev, Denmark. Email: Jacob.rosenberg@regionh.dk.
丹麦赫列夫医院外科;哥本哈根大学,København,丹麦;丹麦霍森斯医院外科;丹麦København Bispebjerg医院外科:(I)构思与设计:所有作者;行政支助:无;(三)提供研究材料或患者:无;(四)数据收集和汇编:所有作者;(五)数据分析和解释:所有作者;(六)稿件撰写:全体作者;(七)稿件最终审定:全体作者。通讯作者:Jacob Rosenberg。丹麦赫列夫医院外科。电子邮件:Jacob.rosenberg@regionh.dk。
{"title":"Variables in the Danish Hernia Databases: inguinal and ventral","authors":"J. Rosenberg, H. Friis-Andersen, L. Jørgensen, K. Andresen","doi":"10.21037/LS-20-125","DOIUrl":"https://doi.org/10.21037/LS-20-125","url":null,"abstract":"Department of Surgery, Herlev Hospital, Herlev, Denmark; University of Copenhagen, København, Denmark; Department of Surgery, Horsens Hospital, Horsens, Denmark; Department of Surgery, Bispebjerg Hospital, København, Denmark Contributions: (I) Conception and design: All authors; (II) Administrative support: None; (III) Provision of study materials or patients: None; (IV) Collection and assembly of data: All authors; (V) Data analysis and interpretation: All authors; (VI) Manuscript writing: All authors; (VII) Final approval of manuscript: All authors. Correspondence to: Jacob Rosenberg. Department of Surgery, Herlev Hospital, Herlev, Denmark. Email: Jacob.rosenberg@regionh.dk.","PeriodicalId":92818,"journal":{"name":"Laparoscopic surgery","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-01-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41792230","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 7
Is robotic-assisted surgery a step in the right direction for routine inguinal hernia repair? 机器人辅助手术是常规腹股沟疝修复的正确方向吗?
Pub Date : 2021-01-14 DOI: 10.21037/LS-20-113
U. Gunnarsson, U. Dahlstrand, K. Strigård
© Laparoscopic Surgery. All rights reserved. Laparosc Surg 2021 | http://dx.doi.org/10.21037/ls-20-113 Until now, the latest technical novelty in inguinal hernia surgery, robotic-assisted repair, has spread without any evidence of its efficacy or safety from randomized clinical trials. In March 2020, however, Prabhu and colleagues (1) from the Cleveland Clinic in the US published the results of what they call a randomized pilot study. The reason for describing it as a “pilot” study was a lack of reliable data for the expected outcome of robotic-assisted surgery compared to conventional laparoscopic inguinal hernia repair. Nevertheless, they designed a multicenter single-blinded protocol conforming to most CONSORT criteria including a total of 102 patients (54 in the conventional laparoscopic arm and 48 in the robotic-assisted arm). Thus, with a strict study design and surgeons experienced in both methods, as applied by the Cleveland group, one can assume that most clinically relevant differences would become manifest in the outcome measures. Another obvious reason for describing this trial as a pilot study is the difficulty in choosing an appropriate main outcome variable that would reveal a significant and clinically relevant improvement in results. This is underlined in an editorial by Jacob Rosenberg (2) published in this Journal in December 2019, commenting on a Chinese observational comparative study on conventional laparoscopic and robotic-assisted rectal resection surgery (3). No relevant advantage regarding complications or conversion rates could be identified for robotic-assisted surgery in that study. With this in mind, it is relevant to spend a few minutes on recapitulating the history of inguinal hernia surgery research on quality improvement, and subsequent changes in main outcome parameters over the past three decades. Inguinal hernia may be regarded as a chronic disorder with surgery being the only cure. In the beginning, repeated recurrence was the expected course after surgery. However, consequent standardization and quality control has reduced the recurrence rates. According to data from the Swedish and Danish national hernia databases the 2-year cumulative recurrence rates were less than 2% (4,5). Improved surgical quality and individual audit of surgeons, as well as the introduction of reinforcement mesh (i.e., the Lichtenstein technique) contributed to this development. A consequence of these low recurrence rates was that studies on hernia repair with recurrence as the main outcome variable became difficult to design and carry out. Such studies required the inclusion of thousands of patients to achieve acceptable power. This led to a paradigm shift where randomized trials adopted new main outcome variables. Long-term pain has become one of the most common of these. Depending on the definition of pain and when its estimation is performed, up to 30% of patients claim some degree of pain the past week and more than 5% suffer fro
©腹腔镜手术。版权所有。腹腔镜手术2021 | http://dx.doi.org/10.21037/ls-20-113到目前为止,腹股沟疝手术的最新技术新颖,机器人辅助修复,已经传播,没有任何证据表明其有效性或安全性从随机临床试验。然而,2020年3月,美国克利夫兰诊所的普拉布和他的同事发表了他们所谓的随机试点研究的结果。将其描述为“试点”研究的原因是,与传统腹腔镜腹股沟疝修补术相比,缺乏机器人辅助手术预期结果的可靠数据。然而,他们设计了一个符合大多数CONSORT标准的多中心单盲方案,共包括102例患者(54例在传统腹腔镜臂,48例在机器人辅助臂)。因此,有了严格的研究设计和经验丰富的外科医生,如克利夫兰小组所应用的,我们可以假设大多数临床相关的差异将在结果测量中表现出来。将该试验描述为先导研究的另一个明显原因是难以选择适当的主要结局变量来显示结果的显着和临床相关的改善。雅各布·罗森伯格(Jacob Rosenberg)于2019年12月在本刊发表的一篇社论(2)中强调了这一点,评论了中国对传统腹腔镜和机器人辅助直肠切除手术的观察性比较研究(3)。在该研究中,机器人辅助手术在并发症或转换率方面没有相关优势。考虑到这一点,有必要花几分钟时间回顾一下过去三十年来腹股沟疝手术质量改善的研究历史,以及随后主要结局参数的变化。腹股沟疝可视为一种慢性疾病,手术是唯一的治疗方法。一开始,反复复发是手术后的预期过程。然而,随之而来的标准化和质量控制降低了复发率。根据瑞典和丹麦国家疝气数据库的数据,2年累积复发率小于2%(4,5)。手术质量的提高和外科医生的个人审核,以及强化补片(即利希滕斯坦技术)的引入促进了这一发展。这些低复发率的结果是,以复发为主要结局变量的疝气修复研究变得难以设计和实施。这样的研究需要纳入数千名患者才能达到可接受的疗效。这导致了范式的转变,随机试验采用了新的主要结果变量。长期疼痛已经成为其中最常见的一种。根据疼痛的定义和评估时间的不同,高达30%的患者声称在过去一周有一定程度的疼痛,超过5%的患者患有干扰日常活动的疼痛(6)。几种用于标准化测量疼痛的工具,如腹股沟疼痛问卷(7)和卡罗莱纳社论评论
{"title":"Is robotic-assisted surgery a step in the right direction for routine inguinal hernia repair?","authors":"U. Gunnarsson, U. Dahlstrand, K. Strigård","doi":"10.21037/LS-20-113","DOIUrl":"https://doi.org/10.21037/LS-20-113","url":null,"abstract":"© Laparoscopic Surgery. All rights reserved. Laparosc Surg 2021 | http://dx.doi.org/10.21037/ls-20-113 Until now, the latest technical novelty in inguinal hernia surgery, robotic-assisted repair, has spread without any evidence of its efficacy or safety from randomized clinical trials. In March 2020, however, Prabhu and colleagues (1) from the Cleveland Clinic in the US published the results of what they call a randomized pilot study. The reason for describing it as a “pilot” study was a lack of reliable data for the expected outcome of robotic-assisted surgery compared to conventional laparoscopic inguinal hernia repair. Nevertheless, they designed a multicenter single-blinded protocol conforming to most CONSORT criteria including a total of 102 patients (54 in the conventional laparoscopic arm and 48 in the robotic-assisted arm). Thus, with a strict study design and surgeons experienced in both methods, as applied by the Cleveland group, one can assume that most clinically relevant differences would become manifest in the outcome measures. Another obvious reason for describing this trial as a pilot study is the difficulty in choosing an appropriate main outcome variable that would reveal a significant and clinically relevant improvement in results. This is underlined in an editorial by Jacob Rosenberg (2) published in this Journal in December 2019, commenting on a Chinese observational comparative study on conventional laparoscopic and robotic-assisted rectal resection surgery (3). No relevant advantage regarding complications or conversion rates could be identified for robotic-assisted surgery in that study. With this in mind, it is relevant to spend a few minutes on recapitulating the history of inguinal hernia surgery research on quality improvement, and subsequent changes in main outcome parameters over the past three decades. Inguinal hernia may be regarded as a chronic disorder with surgery being the only cure. In the beginning, repeated recurrence was the expected course after surgery. However, consequent standardization and quality control has reduced the recurrence rates. According to data from the Swedish and Danish national hernia databases the 2-year cumulative recurrence rates were less than 2% (4,5). Improved surgical quality and individual audit of surgeons, as well as the introduction of reinforcement mesh (i.e., the Lichtenstein technique) contributed to this development. A consequence of these low recurrence rates was that studies on hernia repair with recurrence as the main outcome variable became difficult to design and carry out. Such studies required the inclusion of thousands of patients to achieve acceptable power. This led to a paradigm shift where randomized trials adopted new main outcome variables. Long-term pain has become one of the most common of these. Depending on the definition of pain and when its estimation is performed, up to 30% of patients claim some degree of pain the past week and more than 5% suffer fro","PeriodicalId":92818,"journal":{"name":"Laparoscopic surgery","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-01-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44790028","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Narrative review of fluorescence imaging-guided liver surgery 荧光成像引导下肝脏手术的述评
Pub Date : 2021-01-11 DOI: 10.21037/LS-20-102
Y. Gyoda, Y. Mise, M. Terasawa, H. Ichida, T. Mizuno, R. Yoshioka, H. Imamura, A. Saiura
Indocyanine green (ICG) fluorescence imaging has come to be applied to hepatobiliary surgery not only visualization of bile duct but also for identification of subcapsular hepatic tumors and segmental boundaries. A large proportion of ICG molecules bind to high molecular-weight proteins such as albumin. ICG is selectively taken up to hepatocytes and excreted in the bile by an active transporter. Fusion ICG fluorescence images are obtained using a complementary metal-oxide semiconductor camera head and a near-infrared laser diode for ICG excitation. This method is helpful especially in cases of laparoscopic hepatectomy, wherein there is limited visual inspection and palpation in comparison with open surgery. ICG cholangiography is effective for visualizing the confluence of the left and right hepatic duct, decreasing the potential risks of bile duct stenosis or injury. ICG fluorescence imaging is also useful for the visualization of hepatic segment boundaries, which helps navigate the transection line in real time during hepatectomy. However, in the case of liver cirrhosis, the function of liver cells is depressed, and longtime ICG remains in the lesions; thus, the disappearance of fluorescence is delayed. ICG fluorescence imaging is a simple technology with the potential to improve the safety and quality of open, laparoscopic, and robotic
吲哚菁绿(ICG)荧光成像已被应用于肝胆外科,不仅可以显示胆管,还可以识别包膜下肝肿瘤和节段边界。大部分ICG分子与高分子量蛋白质如白蛋白结合。ICG选择性地被肝细胞吸收,并通过活性转运蛋白在胆汁中排泄。使用互补金属氧化物半导体相机头和用于ICG激发的近红外激光二极管获得融合ICG荧光图像。这种方法特别有助于腹腔镜肝切除术,与开放手术相比,腹腔镜肝切除手术的视觉检查和触诊有限。ICG胆管造影可有效显示左右肝管的汇合,降低胆管狭窄或损伤的潜在风险。ICG荧光成像也有助于肝段边界的可视化,这有助于在肝切除术期间实时导航横断线。然而,在肝硬化的情况下,肝细胞的功能受到抑制,并且长期ICG保留在病变中;从而延迟了荧光的消失。ICG荧光成像是一种简单的技术,有可能提高开放式、腹腔镜和机器人的安全性和质量
{"title":"Narrative review of fluorescence imaging-guided liver surgery","authors":"Y. Gyoda, Y. Mise, M. Terasawa, H. Ichida, T. Mizuno, R. Yoshioka, H. Imamura, A. Saiura","doi":"10.21037/LS-20-102","DOIUrl":"https://doi.org/10.21037/LS-20-102","url":null,"abstract":"Indocyanine green (ICG) fluorescence imaging has come to be applied to hepatobiliary surgery not only visualization of bile duct but also for identification of subcapsular hepatic tumors and segmental boundaries. A large proportion of ICG molecules bind to high molecular-weight proteins such as albumin. ICG is selectively taken up to hepatocytes and excreted in the bile by an active transporter. Fusion ICG fluorescence images are obtained using a complementary metal-oxide semiconductor camera head and a near-infrared laser diode for ICG excitation. This method is helpful especially in cases of laparoscopic hepatectomy, wherein there is limited visual inspection and palpation in comparison with open surgery. ICG cholangiography is effective for visualizing the confluence of the left and right hepatic duct, decreasing the potential risks of bile duct stenosis or injury. ICG fluorescence imaging is also useful for the visualization of hepatic segment boundaries, which helps navigate the transection line in real time during hepatectomy. However, in the case of liver cirrhosis, the function of liver cells is depressed, and longtime ICG remains in the lesions; thus, the disappearance of fluorescence is delayed. ICG fluorescence imaging is a simple technology with the potential to improve the safety and quality of open, laparoscopic, and robotic","PeriodicalId":92818,"journal":{"name":"Laparoscopic surgery","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-01-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41944152","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Endoscopic resection of GIST: feasible or fairytale? 内镜下切除GIST:可行还是童话?
Pub Date : 2021-01-01 DOI: 10.21037/ls-20-136
M. Colombo, M. Spadaccini, R. Maselli
{"title":"Endoscopic resection of GIST: feasible or fairytale?","authors":"M. Colombo, M. Spadaccini, R. Maselli","doi":"10.21037/ls-20-136","DOIUrl":"https://doi.org/10.21037/ls-20-136","url":null,"abstract":"","PeriodicalId":92818,"journal":{"name":"Laparoscopic surgery","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42171271","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ethical considerations when implementing new technology into the operating room 在手术室实施新技术时的伦理考虑
Pub Date : 2021-01-01 DOI: 10.21037/ls-22-19
Ryan B Morgan, P. Angelos
{"title":"Ethical considerations when implementing new technology into the operating room","authors":"Ryan B Morgan, P. Angelos","doi":"10.21037/ls-22-19","DOIUrl":"https://doi.org/10.21037/ls-22-19","url":null,"abstract":"","PeriodicalId":92818,"journal":{"name":"Laparoscopic surgery","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42940516","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The gist of surgical margins in GIST: a narrative review gist中手术切缘的要点:叙述回顾
Pub Date : 2021-01-01 DOI: 10.21037/LS-20-139
F. Cananzi, Laura Ruspi, L. Samà, S. Renne, F. Sicoli, V. Quagliuolo
The role of margin status as a prognostic factor in gastrointestinal stromal tumour (GIST) remains a matter of debate. It is clear that R2 resection is predictive of poor outcomes, but the impact of R1 versus R0 surgery on survival varies among studies. The occurrence of spontaneous or iatrogenic rupture may explain this heterogeneity in survival and recurrence rates in the literature. Even if residual disease and rupture do have an impact on the prognosis of GIST patients, their role needs to be better clarified, also in the perspective of introducing one or both of these parameters in a proper staging system. Again, the role of margin status should be deeply investigated in order to give clinicians a reliable safety when planning perioperative strategy. Although GIST should be managed by a multidisciplinary team in a referral center and there is no doubt that R0 surgery without rupture of the tumour is the gold standard, in everyday clinical practice this result is not always reasonably achievable: in some cases surgery may leave a microscopic residual and manipulation of large tumours may result in spillage of neoplastic cells in the abdominal cavity. In this review article, the effect of margins itself and the existence of other possible factors influencing prognosis of GIST patients are explored.
边缘状态作为胃肠道间质瘤(GIST)的预后因素的作用仍然存在争议。很明显,R2切除术可预测不良结果,但R1与R0手术对生存率的影响因研究而异。自发性或医源性破裂的发生可以解释文献中存活率和复发率的异质性。即使残余疾病和破裂确实对GIST患者的预后有影响,也需要更好地阐明它们的作用,也需要在适当的分期系统中引入其中一个或两个参数。再次,应深入研究边缘状态的作用,以便在规划围手术期策略时为临床医生提供可靠的安全性。尽管GIST应由转诊中心的多学科团队进行管理,并且毫无疑问,在没有肿瘤破裂的情况下进行R0手术是金标准,在日常临床实践中,这一结果并不总是合理实现的:在某些情况下,手术可能会留下显微镜下的残留物,而对大肿瘤的操作可能会导致肿瘤细胞溢出腹腔。在这篇综述文章中,探讨了边缘本身的影响以及影响GIST患者预后的其他可能因素的存在。
{"title":"The gist of surgical margins in GIST: a narrative review","authors":"F. Cananzi, Laura Ruspi, L. Samà, S. Renne, F. Sicoli, V. Quagliuolo","doi":"10.21037/LS-20-139","DOIUrl":"https://doi.org/10.21037/LS-20-139","url":null,"abstract":"The role of margin status as a prognostic factor in gastrointestinal stromal tumour (GIST) remains a matter of debate. It is clear that R2 resection is predictive of poor outcomes, but the impact of R1 versus R0 surgery on survival varies among studies. The occurrence of spontaneous or iatrogenic rupture may explain this heterogeneity in survival and recurrence rates in the literature. Even if residual disease and rupture do have an impact on the prognosis of GIST patients, their role needs to be better clarified, also in the perspective of introducing one or both of these parameters in a proper staging system. Again, the role of margin status should be deeply investigated in order to give clinicians a reliable safety when planning perioperative strategy. Although GIST should be managed by a multidisciplinary team in a referral center and there is no doubt that R0 surgery without rupture of the tumour is the gold standard, in everyday clinical practice this result is not always reasonably achievable: in some cases surgery may leave a microscopic residual and manipulation of large tumours may result in spillage of neoplastic cells in the abdominal cavity. In this review article, the effect of margins itself and the existence of other possible factors influencing prognosis of GIST patients are explored.","PeriodicalId":92818,"journal":{"name":"Laparoscopic surgery","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41390414","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Indications and limits of minimally invasive treatment of esophageal gastrointestinal stromal tumor: a narrative review 食管胃肠道间质瘤微创治疗的适应证和局限性:叙述性综述
Pub Date : 2021-01-01 DOI: 10.21037/LS-20-121
C. Aquina, S. Melo, C. Contreras
: Esophageal gastrointestinal stromal tumor (GIST) is a rare neoplasm that arises from interstitial cells of Cajal that typically requires surgical resection due to its potential for aggressive behavior. These tumors can affect any site of the digestive tract, from the esophagus to the rectum. Though they arise from the submucosal layer, they can ulcerate through the mucosa or form pedunculated masses. Esophageal GIST generally has a worse outcome compared to tumors arising in the stomach. The preoperative evaluation includes imaging and endoscopic ultrasound (EUS) to obtain a tissue biopsy. For large, locally advanced, or metastatic tumors, neoadjuvant tyrosine kinase inhibitor therapy should be strongly considered. Tumor genotyping can help identify imatinib non-responders or those requiring a higher dose. Due to the rarity of regional nodal metastasis, surgical options include esophagectomy, tumor enucleation, and submucosal tunneling endoscopic resection (STER). Given a high risk of postoperative morbidity, esophagectomy should be avoided in favor of the less invasive enucleation or endoscopic resection. Thoracoscopic/laparoscopic and robotic-assisted enucleation and STER are minimally invasive operative approaches that appear to be safe with adequate oncologic outcomes based on currently available evidence. Adjuvant therapy should be considered for high-risk tumors, though the optimal duration of therapy remains under investigation. images and demonstrate enhancement after gadolinium administration. The marked tissue hypersignal visualized on T2-weighted images are strongly correlated with a diagnosis of a GIST (13,15). Similar to CT, MRI allows for measurement of the tumor, detection of locally advanced GIST, and evaluation of liver metastasis.
食道胃肠道间质瘤(GIST)是一种罕见的肿瘤,起源于Cajal间质细胞,由于其潜在的侵袭性行为,通常需要手术切除。这些肿瘤可以影响消化道的任何部位,从食道到直肠。虽然它们起源于粘膜下层,但它们可以通过粘膜溃烂或形成带蒂的肿块。与胃肿瘤相比,食道间质瘤的预后通常更差。术前评估包括影像学和超声内镜(EUS)以获得组织活检。对于大的,局部晚期的,或转移性肿瘤,新辅助酪氨酸激酶抑制剂治疗应强烈考虑。肿瘤基因分型可以帮助识别伊马替尼无反应或需要更高剂量的患者。由于罕见的区域淋巴结转移,手术选择包括食管切除术,肿瘤去核和粘膜下隧道内镜切除(STER)。考虑到术后发病率高的风险,应避免食管切除术,而应选择侵入性较小的去核或内镜切除。根据现有证据,胸腔镜/腹腔镜、机器人辅助摘除和STER是安全的微创手术方式,具有良好的肿瘤预后。高危肿瘤应考虑辅助治疗,但最佳治疗时间仍在研究中。钆强化后的图像和影像增强。在t2加权图像上可见的明显组织高信号与GIST的诊断密切相关(13,15)。与CT类似,MRI可以测量肿瘤,检测局部晚期GIST,并评估肝转移。
{"title":"Indications and limits of minimally invasive treatment of esophageal gastrointestinal stromal tumor: a narrative review","authors":"C. Aquina, S. Melo, C. Contreras","doi":"10.21037/LS-20-121","DOIUrl":"https://doi.org/10.21037/LS-20-121","url":null,"abstract":": Esophageal gastrointestinal stromal tumor (GIST) is a rare neoplasm that arises from interstitial cells of Cajal that typically requires surgical resection due to its potential for aggressive behavior. These tumors can affect any site of the digestive tract, from the esophagus to the rectum. Though they arise from the submucosal layer, they can ulcerate through the mucosa or form pedunculated masses. Esophageal GIST generally has a worse outcome compared to tumors arising in the stomach. The preoperative evaluation includes imaging and endoscopic ultrasound (EUS) to obtain a tissue biopsy. For large, locally advanced, or metastatic tumors, neoadjuvant tyrosine kinase inhibitor therapy should be strongly considered. Tumor genotyping can help identify imatinib non-responders or those requiring a higher dose. Due to the rarity of regional nodal metastasis, surgical options include esophagectomy, tumor enucleation, and submucosal tunneling endoscopic resection (STER). Given a high risk of postoperative morbidity, esophagectomy should be avoided in favor of the less invasive enucleation or endoscopic resection. Thoracoscopic/laparoscopic and robotic-assisted enucleation and STER are minimally invasive operative approaches that appear to be safe with adequate oncologic outcomes based on currently available evidence. Adjuvant therapy should be considered for high-risk tumors, though the optimal duration of therapy remains under investigation. images and demonstrate enhancement after gadolinium administration. The marked tissue hypersignal visualized on T2-weighted images are strongly correlated with a diagnosis of a GIST (13,15). Similar to CT, MRI allows for measurement of the tumor, detection of locally advanced GIST, and evaluation of liver metastasis.","PeriodicalId":92818,"journal":{"name":"Laparoscopic surgery","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49043352","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
A novel concept on the origin of gastroesophageal reflux disease 胃食管反流病起源的新概念
Pub Date : 2021-01-01 DOI: 10.21037/ls-22-32
M. Fanous
{"title":"A novel concept on the origin of gastroesophageal reflux disease","authors":"M. Fanous","doi":"10.21037/ls-22-32","DOIUrl":"https://doi.org/10.21037/ls-22-32","url":null,"abstract":"","PeriodicalId":92818,"journal":{"name":"Laparoscopic surgery","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49257223","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Planning the treatment: preoperative 3D reconstruction 计划治疗:术前3D重建
Pub Date : 2021-01-01 DOI: 10.21037/ls-22-6
R. Santambrogio, M. Vertemati, Edgardo Picardi, M. Zappa
{"title":"Planning the treatment: preoperative 3D reconstruction","authors":"R. Santambrogio, M. Vertemati, Edgardo Picardi, M. Zappa","doi":"10.21037/ls-22-6","DOIUrl":"https://doi.org/10.21037/ls-22-6","url":null,"abstract":"","PeriodicalId":92818,"journal":{"name":"Laparoscopic surgery","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44372249","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
期刊
Laparoscopic surgery
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1